Regenxbio (RGNX) EBITDA Margin Growth (3y) (2017 - 2025)
Regenxbio (RGNX) EBITDA Margin Growth (3y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Regenxbio |
315.11 Mn |
85.04 Mn |
- |
-3,936.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-3,936.00 |
| Sep 30, 2025 |
8,990.00 |
| Jun 30, 2025 |
-11,431.00 |
| Mar 31, 2025 |
39,435.00 |
| Dec 31, 2024 |
-31,547.00 |
| Sep 30, 2024 |
-4,945.00 |
| Jun 30, 2024 |
2,771.00 |
| Mar 31, 2024 |
-12,686.00 |
| Dec 31, 2023 |
-5,115.00 |
| Sep 30, 2023 |
-21,308.00 |
| Jun 30, 2023 |
-15,732.00 |
| Mar 31, 2023 |
-9,728.00 |
| Dec 31, 2022 |
4,412.00 |
| Sep 30, 2022 |
-6,189.00 |
| Jun 30, 2022 |
-20,568.00 |
| Mar 31, 2022 |
318,791.00 |
| Dec 31, 2021 |
6,249.00 |
| Sep 30, 2021 |
17,394.00 |
| Jun 30, 2021 |
-28,786.00 |
| Mar 31, 2021 |
-34,944.00 |
